LENSAR (NASDAQ:LNSR – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Thursday, November 7th. Persons interested in registering for the company’s earnings conference call can do so using this link.
LENSAR (NASDAQ:LNSR – Get Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.53) earnings per share (EPS) for the quarter. LENSAR had a negative return on equity of 30.69% and a negative net margin of 27.83%. The firm had revenue of $12.64 million during the quarter.
LENSAR Price Performance
NASDAQ:LNSR traded up $0.14 during trading hours on Tuesday, hitting $6.00. 14,714 shares of the stock traded hands, compared to its average volume of 32,390. LENSAR has a 1 year low of $1.80 and a 1 year high of $6.25. The stock has a 50 day moving average price of $4.87 and a 200 day moving average price of $4.51.
LENSAR Company Profile
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
Read More
- Five stocks we like better than LENSAR
- Trading Stocks: RSI and Why it’s Useful
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Calculate Inflation Rate
- Insider Buying Signals Upside for These 3 Stocks
- Business Services Stocks Investing
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.
